Peptide-Based Vaccination Therapy for Rheumatic Diseases

Peptide-Based Vaccination Therapy for Rheumatic Diseases

Rheumatic diseases are extremely heterogeneous diseases with substantial risks of morbidity and mortality, and there is a pressing need in developing more safe and cost-effective treatment strategies. Peptide-based vaccination is a highly desirable strategy in treating noninfection diseases, such as...

Full description

Bibliographic Details
Main Authors:	Bin Wang, Shiju Chen, Qing Zheng, Yuan Liu, Guixiu Shi
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/8060375

Similar Items

The Role of IL-33 in Rheumatic Diseases
by: Lihua Duan, et al.
Published: (2013-01-01)

Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
by: Hongyan Qian, et al.
Published: (2020-11-01)

Vaccination of children with rheumatic Diseases
by: M. P. Kostinov, et al.
Published: (2016-06-01)

Vaccination of Children with Rheumatic Diseases
by: M. P. Tostinov, et al.
Published: (2015-12-01)

Vaccination of Children with Rheumatic Diseases
by: M. P. Ustinov, et al.
Published: (2016-02-01)

Vaccinations in autoimmune inflammatory rheumatic diseases
by: Leszek Szenborn
Published: (2016-12-01)

VACCINATION IN RHEUMATIC DISEASES: AN ALLY OR AN ENEMY?
by: B. S. Belov
Published: (2018-09-01)

Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01)

Current Therapy of Emergencies in Rheumatic Diseases
by: V.I. Denysiuk, et al.
Published: (2013-02-01)

TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2016-12-01)

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
by: Cinzia Rotondo, et al.
Published: (2021-07-01)

Peptide Vaccine Therapy in Colorectal Cancer
by: Shi-Yu Yang, et al.
Published: (2012-08-01)

Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases
by: Ahmad AlEnizi, et al.
Published: (2018-01-01)

Mesenchymal Stem Cell Therapy for rheumatic diseases
by: Yeung Winnie Wan-Yin, et al.
Published: (2016-08-01)

Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01)

Preventing rheumatic fever: M-protein based vaccine
by: Rajendra Tandon
Published: (2014-01-01)

Place of cyclosporin A in the therapy of rheumatic diseases
by: Zemfira Sadullaevna Alekberova, et al.
Published: (2011-09-01)

Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy
by: S K Solov'ev, et al.
Published: (2009-06-01)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
by: van der Klis F, et al.
Published: (2011-09-01)

CURRENT RECOMMENDATIONS REGARDING VACCINATION OF PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES
by: Ramona Stefania Popescu, et al.
Published: (2017-03-01)

Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
by: Hsin-Hua Chen, et al.
Published: (2018-01-01)

A novel approach for characterizing variations in serum peptides in rheumatic heart disease
by: Xiaochen Wu, et al.
Published: (2017-01-01)

Lipid Metabolism Profiles in Rheumatic Diseases
by: Weilin Chen, et al.
Published: (2021-04-01)

Trial watch: Peptide-based vaccines in anticancer therapy
by: Lucillia Bezu, et al.
Published: (2018-12-01)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
by: Cantatore FP, et al.
Published: (2017-12-01)

Molecular Mechanism of Rheumatic Diseases and Efficacy of Current Therapies
by: Sadiq Umar, et al.
Published: (2017-01-01)

Infections after Biologic Agent Therapy in rheumatic diseases
by: S. Kinikli, et al.
Published: (2014-04-01)

Efficacy and tolerance of stepwise therapy withmovalis in rheumatic diseases
by: E S Tsvetkova
Published: (2004-12-01)

PREVENTION OF RHEUMATIC HEART DISEASE AND RHEUMATIC FEVER
by: Namrata Khanal
Published: (2003-01-01)

Assessment of the vaccination status in rheumatic disease patients treated with disease-modifying antirheumatic drugs
by: Luisa Brites, et al.
Published: (2019-07-01)

Towards a Vaccine Against Rheumatic Fever
by: L. Guilherme, et al.
Published: (2006-01-01)

Spine and Rheumatic Diseases
by: James Cheng-Chung Wei, et al.
Published: (2015-01-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
by: Justin P Zachariah, et al.
Published: (2016-01-01)

Advanced therapies for inflammatory rheumatic diseases in resource-poor settings
by: Vinod Chandran
Published: (2019-01-01)

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
by: Hanna Graßhoff, et al.
Published: (2021-04-01)

Coronary Artery Disease in Rheumatic and Non-Rheumatic Valvular Heart Disease
by: Uzma Gul, et al.
Published: (2018-12-01)

Calcium therapy in muscular rheumatism
by: Smith, H. E.
Published: (1930)

Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis
by: S. G. Anikin, et al.
Published: (2019-05-01)

Drug therapy in patients with rheumatic diseases during pregnancy and lactation
by: Nadezhda Mikhailovna Kosheleva, et al.
Published: (2011-08-01)